Publications by authors named "David M Peereboom"

66Publications

A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.

Neurosurgery 2021 Jan;88(2):246-251

The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article and Find Full Text PDF
January 2021

Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.

J Neurooncol 2020 Mar 5;147(1):171-176. Epub 2020 Feb 5.

Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, L603, Portland, OR, 97239, USA.

View Article and Find Full Text PDF
March 2020

Large B-cell lymphoma of the uvea: Histopathologic variants and clinicopathologic correlation.

Surv Ophthalmol 2020 May - Jun;65(3):361-370. Epub 2019 Oct 30.

Department of Ophthalmic Oncology, Cole Eye Institute of the Cleveland, Cleveland, OH, USA. Electronic address:

View Article and Find Full Text PDF
October 2019

Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.

Int J Radiat Oncol Biol Phys 2019 12 25;105(5):1106-1112. Epub 2019 Aug 25.

Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio.

View Article and Find Full Text PDF
December 2019

Phase II study of Dovitinib in recurrent glioblastoma.

J Neurooncol 2019 Sep 11;144(2):359-368. Epub 2019 Jul 11.

Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, S73, Cleveland, OH, 44195, USA.

View Article and Find Full Text PDF
September 2019

Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.

Int J Radiat Oncol Biol Phys 2019 08 22;104(5):1099-1105. Epub 2019 Apr 22.

Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article and Find Full Text PDF
August 2019

Risk Factors for Malignant Transformation of Low-Grade Glioma.

Int J Radiat Oncol Biol Phys 2018 03 21;100(4):965-971. Epub 2017 Dec 21.

Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio; Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.

View Article and Find Full Text PDF
March 2018

Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

Neurosurgery 2018 09;83(3):385-392

Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Department of Neurosurgery, Neurological Institute, Cleveland Clinic, Cleveland, Ohio.

View Article and Find Full Text PDF
September 2018

Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.

Pract Radiat Oncol 2017 Nov - Dec;7(6):e391-e399. Epub 2017 Apr 12.

Department of Radiation Oncology, Cleveland Clinic Radiation Oncology, Cleveland, Ohio; Rose Ella Burkhardt Brain Tumor and Neuro-oncology Center, Cleveland, Ohio.

View Article and Find Full Text PDF
July 2018